Advertisement
Health in Action

Health in Action The Health in Action section provides a place where groups or individuals who are not represented regularly in a medical journal have a forum to describe the important issues from their perspective. Authors might include patient advocacy groups, healthcare workers, or non-governmental organizations.

See all article types »

Developing ANDI: A Novel Approach to Health Product R&D in Africa

  • Solomon Nwaka mail,

    nwakas@who.int

    Affiliation: UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland

    X
  • Tshinko B. Ilunga,

    Affiliation: African Development Bank, Tunis-Belvedère, Tunisia

    X
  • Jorge Santos Da Silva,

    Affiliation: McKinsey & Company, Geneva, Switzerland

    X
  • Emiliano Rial Verde,

    Affiliation: McKinsey & Company, Geneva, Switzerland

    X
  • Doan Hackley,

    Affiliation: McKinsey & Company, Geneva, Switzerland

    X
  • Raymond De Vré,

    Affiliation: McKinsey & Company, Geneva, Switzerland

    X
  • Tom Mboya-Okeyo,

    Affiliation: Permanent Mission of the Republic of Kenya to the United Nations and Other International Organizations, Geneva, Switzerland

    X
  • Robert G. Ridley

    Affiliation: UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland

    X
  • Published: June 29, 2010
  • DOI: 10.1371/journal.pmed.1000293
  • Featured in PLOS Collections

About the Authors

Solomon Nwaka, Robert G. Ridley
UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland
Tshinko B. Ilunga
African Development Bank, Tunis-Belvedère, Tunisia
Jorge Santos Da Silva, Emiliano Rial Verde, Doan Hackley, Raymond De Vré
McKinsey & Company, Geneva, Switzerland
Tom Mboya-Okeyo
Permanent Mission of the Republic of Kenya to the United Nations and Other International Organizations, Geneva, Switzerland

Corresponding Author

Email: nwakas@who.int

Competing Interests

JDS, ERV, DH, and RDV are paid consultants by WHO/TDR in the development of the strategic business plan for ANDI. TBI is a member of Pfizer's Emerging Markets Customer Advisory Board.

Author Contributions

ICMJE criteria for authorship read and met: SN TBI JSdS ERRV DH RDV TMO RGR. Agree with the manuscript's results and conclusions: SN TBI JSdS ERRV DH RDV TMO RGR. Designed the experiments/the study: SN TBI. Analyzed the data: SN TBI JSdS ERRV DH RDV. Collected data/did experiments for the study: SN JSdS ERRV DH RDV. Wrote the first draft of the paper: SN. Contributed to the writing of the paper: TBI JSdS ERRV DH RDV TMO RGR.